Anticancer Therapies – Multimedia

Vaccines are critical for the prevention of infectious diseases and improvement of global health. Better understanding of the immune system and the availability of advanced structural biology tools and genetic delivery systems have unlocked new possibilities to improve vaccine development.

This eBook highlights innovative tools to evaluate the potency of immunotherapies in vitro.

This eBook will provide readers with an overview of drug discovery, design, kinetics and development, highlighting challenges and solutions, successes, various modalities and approaches.

Metabolism is a key driver of CAR-T cell fitness and function. Hence, metabolic preconditioning methods can enhance the bioenergetic capacity of CAR-T cells in culture, supporting their persistence and antitumor activity

Speaking at The Landscape of Cancer Research 2022 online symposium, keynote speaker Grant McFadden of the University of Arizona delivered his talk on recent advances and challenges in oncolytic virotherapy.

Speaking at The Landscape of Cancer Research 2022 online symposium, Eric Kmiec of the Gene Editing Institute, ChristianaCare, delivered his talk on advances in CRISPR gene editing.

Speaking at The Landscape of Cancer Research 2022 online symposium, Sofia Lourenco of Cancer Research Horizons delivered her talk on the challenges facing the future of cancer immunotherapies.

Speaking at The Landscape of Cancer Research 2022 online symposium, James Moon from the University of Michigan delivered his talk on next-generation STING agonists for immunotherapy against advanced cancer.

A vaccine which targets an aggressive form of breast cancer is moving forward to a second trial involving patients fighting cancer.

Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary and promising approach for cancer treatment. However, its potential is limited by technical challenges and safety risks associated with viral transduction–based CAR T-cell generation workflows.